Ning Deng
Jinan University, China
Biography
Ning Deng has his expertise in antibody drug and tumor polypeptide vaccine around tumor angiogenesis inhibition. He has established antibody design and construction system, included the phage antibody library, affinity maturation and improvement based on antibody structural simulation, evaluation system for tumor peptide vaccine. He also researched on the mechanism of tumor angiogenesis in ovarian cancer and stem cell evaluation.
Abstract
Abstract : A new disulfide-stabilized diabody against bFGF and the inhibition of cancer